Fatty Acyl Benzamido Antibacterials Based on Inhibition of DnaK-catalyzed Protein Folding

Journal of Biological Chemistry
2007.0

Abstract

We have reported that the hsp70 chaperone DnaK from Escherichia coli might assist protein folding by catalyzing the cis/trans isomerization of secondary amide peptide bonds in unfolded or partially folded proteins. In this study a series of fatty acylated benzamido inhibitors of the cis/trans isomerase activity of DnaK was developed and tested for antibacterial effects in E. coli MC4100 cells. N(alpha)-[Tetradecanoyl-(4-aminomethylbenzoyl)]-l-asparagine is the most effective antibacterial with a minimal inhibitory concentration of 100 +/- 20 microg/ml. The compounds were shown to compete with fluorophore-labeled sigma(32)-derived peptide for the peptide binding site of DnaK and to increase the fraction of aggregated proteins in heat-shocked bacteria. Despite its inability to serve as a folding helper in vivo a DnaK-inhibitor complex was still able to sequester an unfolded protein in vitro. Structure activity relationships revealed a distinct dependence of DnaK-assisted refolding of luciferase on the fatty acyl chain length, whereas the minimal inhibitory concentration was most sensitive to the structural nature of the benzamido core. We conclude that the isomerase activity of DnaK is a major survival factor in the heat shock response of bacteria and that small molecule inhibitors can lead to functional inactivation of DnaK and thus will display antibacterial activity.

Knowledge Graph

Similar Paper

Fatty Acyl Benzamido Antibacterials Based on Inhibition of DnaK-catalyzed Protein Folding
Journal of Biological Chemistry 2007.0
Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination
European Journal of Medicinal Chemistry 2019.0
Identification of inhibitors of the E. coli chaperone SurA using in silico and in vitro techniques
Bioorganic & Medicinal Chemistry Letters 2018.0
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ
Bioorganic & Medicinal Chemistry Letters 2009.0
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Amidino benzimidazole inhibitors of bacterial two-component systems
Bioorganic & Medicinal Chemistry Letters 2001.0
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
MedChemComm 2016.0
Design and synthesis of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents
European Journal of Medicinal Chemistry 2010.0
Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction
European Journal of Medicinal Chemistry 2020.0